Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$798M |
| 2 |
Netflix
NFLX
|
+$608M |
| 3 |
UnitedHealth
UNH
|
+$517M |
| 4 |
Apple
AAPL
|
+$461M |
| 5 |
GE Vernova
GEV
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$527M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$372M |
| 3 |
Meta Platforms (Facebook)
META
|
+$362M |
| 4 |
Advanced Micro Devices
AMD
|
+$328M |
| 5 |
Palantir
PLTR
|
+$327M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Healthcare | 15.79% |
| 3 | Consumer Discretionary | 12.36% |
| 4 | Financials | 11.53% |
| 5 | Industrials | 8.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1751
Mission Produce
AVO
$1.04B
| $3.48M | ﹤0.01% |
297,000
+241,300
| +433% | +$2.61M |
2024 Q3
3 quarters
|
|
1752
iShares MSCI Europe Financials ETF
EUFN
$3.65B
| $3.48M | ﹤0.01% |
110,000
+38,090
| +53% | +$1.15M |
2024 Q3
3 quarters
|
|
1753
Marten Transport
MRTN
$1.03B
| $3.47M | ﹤0.01% |
+267,350
| New | +$3.52M |
2025 Q2
0 quarters
|
|
1754
Certara
CERT
$1.46B
| $3.47M | ﹤0.01% |
+296,800
| New | +$3.51M |
2025 Q2
0 quarters
|
|
1755
inTEST
INTT
$186M
| $3.47M | ﹤0.01% |
476,489
-27,352
| -5% | -$174K |
2013 Q2
48 quarters
|
|
1756
Amneal Pharmaceuticals
AMRX
$6.82B
| $3.46M | ﹤0.01% |
428,000
-196,700
| -31% | -$1.48M |
2023 Q3
7 quarters
|
|
|
VRE
1757
DELISTED
Veris Residential
VRE
| $3.46M | ﹤0.01% |
232,400
+114,600
| +97% | +$1.76M |
2025 Q1
1 quarter
|
|
1758
DELISTED
Terns Pharmaceuticals
TERN
| $3.44M | ﹤0.01% |
922,534
-511,300
| -36% | -$1.6M |
2024 Q2
4 quarters
|
|
1759
State Street SPDR Portfolio S&P 500 Value ETF
SPYV
$36.5B
| $3.43M | ﹤0.01% |
+65,600
| New | +$3.28M |
2025 Q2
0 quarters
|
|
1760
Liberty Latin America Class C
LILAK
$1.61B
| $3.43M | ﹤0.01% |
607,090
+142,010
| +31% | +$696K |
2021 Q4
14 quarters
|
|
1761
Nordic American Tanker
NAT
$1.86B
| $3.43M | ﹤0.01% |
1,305,000
+240,300
| +23% | +$627K |
2023 Q3
7 quarters
|
|
1762
Byline Bancorp
BY
$1.66B
| $3.43M | ﹤0.01% |
128,300
-100
| -0.1% | -$2.57K |
2018 Q3
27 quarters
|
|
1763
Seanergy Maritime Holdings
SHIP
$376M
| $3.42M | ﹤0.01% |
542,299
-159,901
| -23% | -$963K |
2023 Q4
6 quarters
|
|
1764
DELISTED
Udemy
UDMY
| $3.41M | ﹤0.01% |
485,101
+312,101
| +180% | +$2.15M |
2024 Q2
4 quarters
|
|
1765
The Joint Corp
JYNT
$98.6M
| $3.4M | ﹤0.01% |
294,878
-8,400
| -3% | -$89.9K |
2017 Q4
30 quarters
|
|
1766
DELISTED
Kennedy-Wilson Holdings
KW
| $3.4M | ﹤0.01% |
499,800
+310,400
| +164% | +$2.07M |
2025 Q1
1 quarter
|
|
1767
Ascent Industries
ACNT
$122M
| $3.38M | ﹤0.01% |
267,800
+107,800
| +67% | +$1.37M |
2014 Q4
42 quarters
|
|
1768
ReposiTrak
TRAK
$139M
| $3.37M | ﹤0.01% |
171,563
+6,900
| +4% | +$145K |
2019 Q2
24 quarters
|
|
1769
BCB Bancorp
BCBP
$251M
| $3.37M | ﹤0.01% |
400,194
+58,300
| +17% | +$494K |
2015 Q4
38 quarters
|
|
1770
iShares MSCI Germany ETF
EWG
$1.43B
| $3.37M | ﹤0.01% |
79,600
-102,900
| -56% | -$4.11M |
2024 Q3
3 quarters
|
|
1771
Life360
LIF
$3.47B
| $3.37M | ﹤0.01% |
51,600
+41,500
| +411% | +$2.13M |
2024 Q3
3 quarters
|
|
1772
Primis Financial Corp
FRST
$381M
| $3.37M | ﹤0.01% |
310,313
-5,000
| -2% | -$46K |
2016 Q2
36 quarters
|
|
1773
Penumbra
PEN
$12.6B
| $3.36M | ﹤0.01% |
+13,100
| New | +$3.57M |
2025 Q2
0 quarters
|
|
1774
Gossamer Bio
GOSS
$59.7M
| $3.36M | ﹤0.01% |
34,154
+14,540
| +74% | +$1.27M |
2023 Q4
6 quarters
|
|
1775
Franklin Covey
FC
$210M
| $3.36M | ﹤0.01% |
147,103
-1,100
| -0.7% | -$24.3K |
2013 Q2
48 quarters
|
|
Similar funds
Renaissance Technologies's Q2 2025 Portfolio in Review
As of Q2 2025, Renaissance Technologies held 4,018 positions worth $75.2B, up 14% from $66.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies's Q2 2025 filing shows 612 new, 1,577 increased, 1,314 reduced and 496 closed positions. Its largest new stake was UnitedHealth: 1,352,129 shares worth $422M. The largest sale was Broadcom, an estimated $527M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Renaissance Technologies's largest Q2 2025 buy was UnitedHealth: 1,352,129 shares worth $422M.
- Renaissance Technologies added most to NVIDIA in Q2 2025, an estimated $798M increase.
- Renaissance Technologies's biggest Q2 2025 reduction was Broadcom, cutting an estimated $527M.
- Renaissance Technologies fully exited Advanced Micro Devices in Q2 2025, selling an estimated $328M.
- Renaissance Technologies's ten largest holdings make up 12% of its $75.2B portfolio in Q2 2025.
- Renaissance Technologies opened 612 new positions and closed 496 in Q2 2025.
- Renaissance Technologies's portfolio value rose 14% quarter-over-quarter to $75.2B.
Based on Renaissance Technologies's 13F filing for Q2 2025, filed 13 Aug 2025.